Valuation Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
21:00:02 02/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 366.16 USD | -1.62% |
|
-1.68% | +20.85% |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 9,858 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | 20.04% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 9,109 | 8,893 | 8,751 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | 15.68% | -2.38% | -1.59% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 44x | 43x | 43.3x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | - | - | - |
| PEG | - | - | - | -0x | -0x | -0.6x | 18.83x | -61.41x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.84x | 3.76x | 3.71x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 3.55x | 3.39x | 3.3x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 23x | 21.8x | 20.2x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 31.2x | 28.2x | 26.2x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 29x | 30.2x | 26.4x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 3.45% | 3.32% | 3.79% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,569 | 2,624 | 2,654 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 395.8 | 408.8 | 432.6 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 292 | 315.4 | 334.4 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 366.16 | 366.16 | 366.16 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,738 | - | - |
| Announcement Date | 10/02/22 | 16/02/23 | 15/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 44.73x | 3.6x | 23.34x | - | 9.99B | ||
| 35.13x | 4.15x | 15.59x | 2.44% | 184B | ||
| 20.76x | 3.57x | 12.79x | 2.94% | 118B | ||
| 25.05x | 4.5x | 15.4x | 1.24% | 111B | ||
| 32.34x | 3.11x | 12.55x | 2.2% | 94.58B | ||
| 17.55x | 0.21x | 13.13x | 0.72% | 63.13B | ||
| 31.56x | 7.87x | 20.09x | 1.28% | 55.66B | ||
| 40.33x | 3.62x | 12.32x | 2.11% | 53.9B | ||
| 37.34x | 9.27x | 25.93x | -.--% | 43.42B | ||
| 44.54x | 3.36x | 12.49x | 0.52% | 34.68B | ||
| Average | 32.93x | 4.33x | 16.36x | 1.5% | 76.84B | |
| Weighted average by Cap. | 30.46x | 4.14x | 15.20x | 1.83% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BIO Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















